These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1932610)

  • 21. Effects of thyroid dysfunction on prednisolone and prednisone interconversion and disposition in the rat.
    Murata R; Haughey DB; Jusko WJ
    Drug Metab Dispos; 1990; 18(4):403-8. PubMed ID: 1976060
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relative and absolute bioavailability of prednisone and prednisolone after separate oral and intravenous doses.
    Ferry JJ; Horvath AM; Bekersky I; Heath EC; Ryan CF; Colburn WA
    J Clin Pharmacol; 1988 Jan; 28(1):81-7. PubMed ID: 3350994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inequality of clearance values obtained by intravenous bolus and by steady-state infusion. Prednisolone studies in dogs.
    Frey FJ; Frey BM
    Pharmacology; 1982; 24(6):346-54. PubMed ID: 7111375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kinetics of prednisolone and endogenous cortisol suppression in the elderly.
    Stuck AE; Frey BM; Frey FJ
    Clin Pharmacol Ther; 1988 Apr; 43(4):354-62. PubMed ID: 3356080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prednisolone clearance at steady state in dogs.
    Frey FJ; Frey BM; Greither A; Benet LZ
    J Pharmacol Exp Ther; 1980 Nov; 215(2):287-91. PubMed ID: 7441495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tear Fluid Pharmacokinetics Following Oral Prednisone Administration in Dogs With and Without Conjunctivitis.
    Sebbag L; Yan Y; Smith JS; Allbaugh RA; Wulf LW; Mochel JP
    J Ocul Pharmacol Ther; 2019; 35(6):341-349. PubMed ID: 31070497
    [No Abstract]   [Full Text] [Related]  

  • 27. Representation and quantitation of the binding interaction between prednisone, prednisolone and corticosteroid binding globulin.
    Unadkat JD; Rowland M
    J Pharm Pharmacol; 1984 Sep; 36(9):582-5. PubMed ID: 6149280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prednisone Pharmacokinetics During Pregnancy and Lactation.
    Ryu RJ; Easterling TR; Caritis SN; Venkataramanan R; Umans JG; Ahmed MS; Clark S; Kantrowitz-Gordon I; Hays K; Bennett B; Honaker MT; Thummel KE; Shen DD; Hebert MF
    J Clin Pharmacol; 2018 Sep; 58(9):1223-1232. PubMed ID: 29733485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of body condition on plasma prednisolone and prednisone concentrations in clinically healthy cats after single oral dose administration.
    Center SA; Randolph JF; Warner KL; Simpson KW; Rishniw M
    Res Vet Sci; 2013 Aug; 95(1):225-30. PubMed ID: 23473553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dose-dependent protein binding and disposition of prednisolone in rabbits.
    Rocci ML; Jusko WJ
    J Pharm Sci; 1981 Nov; 70(11):1201-4. PubMed ID: 7299663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A pharmacokinetic comparison of two oral liquid glucocorticoid formulations.
    Kamada AK; Wiener MB; LaVallee NM; Scott MB; Selner JC; Szefler SJ
    Pharmacotherapy; 1997; 17(2):353-6. PubMed ID: 9085328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dose-dependent pharmacokinetics of prednisolone in normal and adrenalectomized rats.
    Boudinot FD; Jusko WJ
    J Pharmacokinet Biopharm; 1986 Oct; 14(5):453-67. PubMed ID: 3806371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altered plasma protein-binding of prednisolone in patients with the nephrotic syndrome.
    Frey FJ; Frey BM
    Am J Kidney Dis; 1984 Mar; 3(5):339-48. PubMed ID: 6702820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disposition of total and unbound prednisolone in renal transplant patients receiving anticonvulsants.
    Gambertoglio JG; Holford NH; Kapusnik JE; Nishikawa R; Saltiel M; Stanik-Lizak P; Birnbaum JL; Hau T; Amend WJ
    Kidney Int; 1984 Jan; 25(1):119-23. PubMed ID: 6374250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disposition of quinidine in the rabbit.
    Guentert TW; Huang JD; Oie S
    J Pharm Sci; 1982 Jul; 71(7):812-5. PubMed ID: 7120069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparative serum pharmacokinetics of prednisone and prednisolone methylsulfobenzoate after oral administration].
    Brion N; Pibarot ML; Atienza P; Robin P; Carbon C
    Presse Med; 1988 Apr; 17(12):569-71. PubMed ID: 2967477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endogenous and exogenous glucocorticoids in cushingoid patients.
    Benet LZ; Frey FJ; Amend WJ; Lozada F; Frey BM
    Drug Intell Clin Pharm; 1982 Nov; 16(11):863-8. PubMed ID: 6756849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Steroid-specific effects of ketoconazole on corticosteroid disposition: unaltered prednisolone elimination.
    Ludwig EA; Slaughter RL; Savliwala M; Brass C; Jusko WJ
    DICP; 1989 Nov; 23(11):858-61. PubMed ID: 2596127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered prednisolone pharmacokinetics in patients with cystic fibrosis.
    Dove AM; Szefler SJ; Hill MR; Jusko WJ; Larsen GL; Accurso FJ
    J Pediatr; 1992 May; 120(5):789-94. PubMed ID: 1578318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prednisone and prednisolone bioavailability in renal transplant patients.
    Gambertoglio JG; Frey FJ; Holford NH; Birnbaum JL; Lizak PS; Vincenti F; Feduska NJ; Salvatierra O; Amend WJ
    Kidney Int; 1982 Apr; 21(4):621-6. PubMed ID: 7047863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.